1. Home
  2. TECX vs BKKT Comparison

TECX vs BKKT Comparison

Compare TECX & BKKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

HOLD

Current Price

$18.42

Market Cap

359.0M

Sector

N/A

ML Signal

HOLD

Logo Bakkt Holdings Inc.

BKKT

Bakkt Holdings Inc.

HOLD

Current Price

$10.57

Market Cap

377.0M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
TECX
BKKT
Founded
2019
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
359.0M
377.0M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
TECX
BKKT
Price
$18.42
$10.57
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
1
Target Price
$81.20
$13.00
AVG Volume (30 Days)
301.7K
1.3M
Earning Date
11-06-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$3,871,476,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$2.04
P/E Ratio
N/A
N/A
Revenue Growth
N/A
107.11
52 Week Low
$13.70
$6.81
52 Week High
$61.07
$49.79

Technical Indicators

Market Signals
Indicator
TECX
BKKT
Relative Strength Index (RSI) 45.34 30.83
Support Level $18.60 $12.35
Resistance Level $20.62 $15.66
Average True Range (ATR) 1.46 1.35
MACD -0.22 0.06
Stochastic Oscillator 5.03 2.00

Price Performance

Historical Comparison
TECX
BKKT

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About BKKT Bakkt Holdings Inc.

Bakkt Holdings Inc operates technology that connects the digital economy by offering a platform for crypto and redeeming loyalty points. Its institutional-grade technology platform provides a custody solution that caters to more experienced market participants to store crypto and provides consumers, businesses, and institutions with the ability to buy, sell, and store crypto in a simple, intuitive digital experience accessed via application programming interfaces (APIs) or embedded web experience and Loyalty offers a full spectrum of content that clients can make available to its customers when redeeming loyalty currencies. It generates revenue in the form of Subscription and service and Transaction revenue.

Share on Social Networks: